Results 171 to 180 of about 149,243 (305)

Use of the Multidimensional Haemophilia Pain Questionnaire (MHPQ) in Patients With Severe Haemophilia A Treated With Emicizumab: A Pilot Cross‐Sectional, Single‐Centre Study

Haemophilia, EarlyView.
ABSTRACT Background Despite effective bleed prevention with Emicizumab, pain remains a relevant clinical burden in adults with severe haemophilia A (sHA). A multidimensional assessment is needed to better characterize contemporary haemophilia‐related pain.
Ilenia Lorenza Calcaterra, Sofia Donnarumma, Guido D'Errico, Carmine De Luca, Chiara Caputo, Paola Ciciola, Ernesto Cimino, Matteo Di Minno   +7 more
wiley   +1 more source

Factors Associated with Hepatitis B and Hepatitis C among Infected Patients in Indonesia and Their Knowledge and Attitude: A Multicenter Observational Study

Acta Medica Indonesiana
Background: Hepatitis B virus (HBV) and Hepatitis C virus (HCV) infections are global health problems, including in Indonesia. The purpose of this study was to assess the knowledge and attitudes about HBV and HCV infection among infected patients in ...
Juferdy Kurniawan, Gita Aprilicia, Hery Djagat Purnomo, Cecilia O Permatawedi, Ulfa Kholili, Tehar Karo-Karo, Haris Widita, Aritantri Darmayani, Arif Nur Widodo, Nenny Agustanti, Saptino Miro, Suyata Suyata, Fauzi Yusuf, Catharina Triwikatmani, Syifa Mustika, Rini R Bachtiar, Fandy Gosal, I Ketut Mariadi, Irsan Hasan   +18 more
doaj   +2 more sources

The diagnostic value of decreased levels of inflammatory markers for the state of hepatitis C virus (HCV) infection. [PDF]

PLoS One
Han L, Bi L, Li X.
europepmc   +1 more source

Hepatitis C Virus (HCV) Infection and Neurocognitive Impairment in Subjects with Mild Liver Disease. [PDF]

J Clin Med, 2023
Amendola-Pires MM, Fakoury MK, Salazar H, De Oliveira SB, Brandão-Mello CE, Schmidt SL.   +5 more
europepmc   +1 more source

Hepatitis C Treatment: A Community-Based, Multidisciplinary Approach to Increase Access and Improve Health Perceptions

, 2012
Hepatitis C is a major international health care dilemma, occurring frequently in populations who suffer from other health care disparities. Hepatitis C is the most common blood-borne infection and the leading cause of liver disease in the United States (
Leigh, Elaine A.
core  

Italian Patients Journey for Gene Therapy in Haemophilia A

Haemophilia, EarlyView.
ABSTRACT Introduction Gene therapy (GT) provides sustained FVIII levels without repeated infusions in Hemophilia A (HA) patients thus overcoming a major limitation of replacement therapy. However, issues remain e.g., patient selection criteria, duration and variability of transgene expression, quality of life and long‐term safety.
Giovanni Di Minno, Gaia Spadarella, Alessandra Borchiellini, Anna Borrelli, Andrea Buzzi, Giancarlo Castaman, Michele Cecchi, Raimondo De Cristofaro, Vincenzo La Mura, Angelo Lupi, Giuseppe Malcangi, Maria Elisa Mancuso, Maria Francesca Mansueto, Cristina Santoro, Rita Carlotta Santoro, Luigi Piero Solimeno, Annarita Tagliaferri, Ezio Zanon, Isabella Garagiola, Flora Peyvandi   +19 more
wiley   +1 more source

Immunotactoid Glomerulopathy in a Patient With HIV and Anti-hepatitis C Virus (HCV) Positivity: A Unique Clinical Entity. [PDF]

Cureus
Wagle A, Shrestha R, Varma N.
europepmc   +1 more source

Clinical Significance of Anti‐Atezolizumab Antibodies in Patients With Unresectable Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab

Hepatology Research, EarlyView.
ABSTRACT Aim Systemic therapy is required for unresectable hepatocellular carcinoma (HCC). Atezolizumab plus bevacizumab (ATZ/BEV) is the recommended first‐line treatment for HCC; however, the development of anti‐drug antibodies (ADAs) against ATZ may impair its therapeutic efficacy. Although ADAs have been reported in other cancers treated with immune
Keishi Ouchi, Jun Inoue, Masashi Ninomiya, Mio Tsuruoka, Kosuke Sato, Kotaro Doi, Kengo Watanabe, Tomoya Sasazaki, Atsushi Masamune   +8 more
wiley   +1 more source

Hepatitis C Virus (HCV) Recurrence and Death After Viral Clearance in an HCV-Viremic Donor to HCV-Negative Kidney Recipient. [PDF]

Kidney Med
He S, Tanaka T, Kim SH, Thomsen D, Katz DA, Thomas CP, Rastogi P, Aziz H, Reed AI.   +8 more
europepmc   +1 more source

Hepatitis C Virus (HCV)-Ribonucleic Acid (RNA) As a Biomarker for Lymphoid Malignancy with HCV Infection. [PDF]

Cancers (Basel), 2023
Tsutsumi Y, Ito S, Shiratori S, Teshima T.   +3 more
europepmc   +1 more source